European Heart Journal
Semaglutide, independent of weight loss, attenuates cardiac and hepatic remodelling in experimental heart failure with preserved ejection fraction
Experiments in animalsInterventions
The paper
Cedars-Sinai Smidt Heart Institute
European Heart Journal, 5 Oct 2026


